Clinical pharmacokinetics of leflunomideROZMAN, Blaz.Clinical pharmacokinetics. 2002, Vol 41, Num 6, pp 421-430, issn 0312-5963Article

Ultrasonographic changes of major salivary glands in primary Sjögren's syndrome Evaluation of a novel scoring systemHOCEVAR, Alojzija; RAINER, Sasa; ROZMAN, Blaz et al.European journal of radiology. 2007, Vol 63, Num 3, pp 379-383, issn 0720-048X, 5 p.Article

Concomitant isolation of protein C inhibitor and unnicked β₂-glycoprotein ICUCNIK, Saga; KRIZAJ, Igor; ROZMAN, Blaz et al.Clinical chemistry and laboratory medicine. 2004, Vol 42, Num 2, pp 171-174, issn 1434-6621, 4 p.Article

Increased Responsiveness of Human Coronary Artery Endothelial Cells in Inflammation and CoagulationLAKOTA, Katja; MRAK-POLJSAK, Katjusa; ROZMAN, Blaz et al.Mediators of inflammation. 2009, Vol 2009, Num 2, issn 0962-9351, 146872.1-146872.8Article

Antibodies against annexin A5 : Detection pitfalls and clinical associationsBOZIC, Borut; IRMAN, Spela; GASPERSIC, Natasa et al.Autoimmunity (Print). 2005, Vol 38, Num 6, pp 425-430, issn 0891-6934, 6 p.Article

The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodiesIRMAN, Spela; SKARABOT, Miha; MUSEVIC, Igor et al.Journal of autoimmunity (Print). 2011, Vol 36, Num 2, pp 98-105, issn 0896-8411, 8 p.Article

Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificityVIZJAK, Alenka; ROTT, Tomaz; KOSELJ-KAJTNA, Mira et al.American journal of kidney diseases. 2003, Vol 41, Num 3, pp 539-549, issn 0272-6386, 11 p.Article

Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patientsBOHANEC GRABAR, Petra; ROZMAN, Blaz; TOMSIC, Matija et al.European journal of clinical pharmacology. 2008, Vol 64, Num 9, pp 871-876, issn 0031-6970, 6 p.Article

Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndromeAGMON-LEVIN, Nancy; KIVITY, Shaye; SHOENFELD, Yehuda et al.Journal of autoimmunity (Print). 2012, Vol 39, Num 3, pp 234-239, issn 0896-8411, 6 p.Article

Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineLARSEN, Arvi; KVIEN, Tore K; ROSENBURG, Ronald et al.Scandinavian journal of rheumatology. 2001, Vol 30, Num 3, pp 135-142, issn 0300-9742Conference Paper

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseTYNDALL, Anthony J; BANNET, Bettina; IANNONE, Florenzo et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 10, pp 1809-1815, issn 0003-4967, 7 p.Article

Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid ArthritisPETRA BOHANEC GRABAR; GRABNAR, Iztok; ROZMAN, Blaz et al.Drug metabolism and disposition. 2009, Vol 37, Num 10, pp 2061-2068, issn 0090-9556, 8 p.Article